AZD-3043: Clinical Trials

4 trials of AZD-3043, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 withdrawn. 4 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 14Completed 3, Withdrawn 1

Follow AZD-3043: new trials by email Literature Review of AZD-3043 trials Research Report on AZD-3043

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Phase I, Single Centre, Study to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD3043
AZD3043 - Safety, Tolerability
Phase 1WithdrawnAstraZeneca2010-03-012012-12-20
AZD Single Ascending Dose Study In Healthy Japanese Subjects
AZD3043 - Healthy
Phase 1CompletedAstraZeneca722009-12-012010-12-10
Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD3043
AZD3043 - Healthy
Phase 1CompletedAstraZeneca722009-09-012009-12-18
Study to Assess the Safety, Tolerability and Pharmacokinetics and Pharmacodynamics of AZD3043
AZD3043 - Healthy
Phase 1CompletedAstraZeneca532009-05-012009-08-28

Sponsors

AstraZeneca (4)

Countries

Sweden (2)  ·  United Kingdom (1)

Top investigators

Johan Wemer (2)  ·  Sigridur Kalman (2)  ·  Stephen Kanes (2)  ·  Brendan Smyth (1)  ·  Darren Wilbraham (1)  ·  Dr. Ulrike Lorch, MFPM FRCA (1)

Results publications

PMID 26097986